Location History:
- Blacksburg, VA (US) (2011)
- Radford, VA (US) (1985 - 2019)
Company Filing History:
18 out of 18 
1 out of 444 
1 out of 10 
Years Active: 1985-2019
Title: **David Maxwell Lyerly: Innovator in Biomarker Development**
Introduction
David Maxwell Lyerly, based in Radford, VA, is a prolific inventor known for his significant contributions to the medical field, specifically regarding Clostridium difficile infections. With an impressive portfolio of 22 patents, Lyerly has dedicated his career to developing innovative solutions that enhance diagnostic methods and treatment options for this challenging disease.
Latest Patents
Among his latest innovations, Lyerly's patent on "Clostridium difficile dehydrogenase and toxin as a biomarker for monitoring infection in patients with Clostridium difficile disease" stands out. This groundbreaking work addresses the complex clinical presentations associated with C. difficile infections, which range from mild diarrhea to severe complications like pseudomembranous colitis and megacolon. His biomarker panel, which includes the detection of antigen (GDH), toxins A and B, and fecal lactoferrin, enables clinicians to differentiate between carrier states and active disease, significantly improving patient management and treatment efficacy.
Career Highlights
Lyerly's career is marked by his roles in influential companies such as TechLab, Inc. and Research, Incorporated. His work in these organizations has propelled advancements in understanding and managing C. difficile infections, leading to better outcomes for patients. The methods developed through his patents reflect his commitment to improving healthcare diagnostics and treatments.
Collaborations
Throughout his career, Lyerly has collaborated with notable professionals, including Tracy Dale Wilkins and James Hunter Boone. These partnerships have further enriched his research and development efforts, allowing him to combine expertise and innovate effectively in the field of infectious diseases.
Conclusion
David Maxwell Lyerly's contributions to the medical industry highlight the vital role of innovation in addressing health challenges. His patents and collaborative work with esteemed colleagues reflect his dedication to advancing the understanding and treatment of Clostridium difficile infections. As the medical community continues to evolve, Lyerly's innovations will undoubtedly pave the way for enhanced patient care and management strategies.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.